QuidelOrtho Corporation

NASDAQ:QDEL

Medical - Instruments & Supplies

Healthcare
$9.57 +0.72%

+$0.09 today

Market cap
$656.62M
Beta
0.76
P/E (TTM)
-0.7
EPS (TTM)
-$17.76
52W Low $9.92High $35.58

Volume 2.13M

Average 2.35M

QDEL Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

QuidelOrtho CorporationNASDAQ: QDEL

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 68.2M shares rose 1.0% year over year, in line with the +1.0% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.6% from the prior quarter. Over 3 fiscal years it compounded at +5.7% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1.0% holds above the trailing-twelve-month pace of +1.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
68.2M+0.6% QoQ
Last fiscal yearDec 2025
67.8M+0.9% YoY
LTMMar 2026
67.93M+1.0% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.0%——
1 year+0.9%——
3-year CAGR+5.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
67.8M USD
Year-over-year change
+0.9%
4-year CAGR
+12.1%

Weighted Avg Shares (Diluted) vs competitors

How QDEL compares with its peers on the latest reported figures

  • QDEL's LTM Mar 2026 weighted avg shares (diluted) of 67.93M shares is the 6th highest of the 9 companies compared; the peer median is 92.1M shares.
  • Its year-over-year change of +1.0% is the 4th highest of 9, against a peer median of -1.3%.
  • Over three fiscal years its annual growth of +5.7% compares with a peer median of -1.4%.
QDEL Competitors Peer median
Weighted Avg Shares (Diluted) for QDEL and competitors
Company Period LTM YoY 3-year CAGR
OPKOPKO Health, Inc.LTM Mar 2026773.08M +12.1%+1.5%
TMOThermo Fisher Scientific Inc.LTM Sep 2026373M -1.7%-1.5%
RVTYRevvity, Inc.LTM Jul 2026113.64M -5.8%-3.6%
DGXQuest Diagnostics IncorporatedLTM Sep 2026112M -0.9%-1.4%
OSUROraSure Technologies, Inc.LTM Mar 202672.2M -3.1%+0.4%
QDELQuidelOrtho CorporationLTM Mar 202667.93M +1.0%+5.7%
NNNNAnbio Biotechnology Class A Ordinary SharesFY202543.89M +3.8%-32.7%
BIOBio-Rad Laboratories, Inc.LTM Jun 202626.93M -3.1%-2.9%
TRIBTrinity Biotech plcLTM Dec 2025618.45K +73.0%+33.7%
Peer median (excluding QDEL) 92.1M-1.3%-1.4%

Competitors are the stored peer set for QDEL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Jan 2023
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.7B3.27B3B2.78B2.73B
Cost of Revenue420.3M1.33B1.5B1.5B1.46B
Gross Profit1.28B1.94B1.5B1.29B1.27B
Gross Margin75.3%59.3%49.9%46.2%46.7%
Research & Development95.7M187.9M246.8M218.7M186.2M
Selling, General & Admin239.6M621M763.2M766.8M746.3M
Operating Expenses372.3M1.09B1.36B3.25B2.19B
Depreciation & Amortization52.7M283.6M457.2M453.4M442M
EBITDA953.3M1.09B607M(1.49B)(488.1M)
EBITDA Margin56.1%33.5%20.2%-53.5%-17.9%
Operating Income906M843.7M139.1M(1.96B)(919.2M)
Operating Margin53.3%25.8%4.6%-70.5%-33.7%
Interest Income300K1.3M2.2M00
Interest Expense700K74.5M178.9M188.3M177.6M
Other Income / Expenses(5.7M)(107.8M)(168.2M)(170.6M)(188.5M)
Income Before Tax900.3M735.9M(29.1M)(2.13B)(1.11B)
Pre-Tax Margin53.0%22.5%-1.0%-76.6%-40.6%
Income Tax Expense196.1M187.2M(19M)(79.5M)24.1M
Net Income704.2M548.7M(10.1M)(2.05B)(1.13B)
Net Margin41.5%16.8%-0.3%-73.7%-41.5%
EPS (Basic)16.749.66(0.15)(30.54)(16.69)
EPS (Diluted)16.439.56(0.15)(30.54)(16.69)
Weighted Avg Shares42.08M56.8M66.8M67.2M67.8M
Weighted Avg Shares (Diluted)42.87M57.4M66.8M67.2M67.8M

QuidelOrtho Corporation

NASDAQ:QDEL

Intrinsic Alpha fair value

Locked

Current Price

$9.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.